Dr. Reddy's Receives GST Demand Orders Totaling ₹8.4 Cr with Penalty

Dr. Reddy's Laboratories Limited has received five separate orders from the Joint Commissioner of Central Tax, Visakhapatnam, pertaining to tax demands, interest, and penalties for the financial years...

Dr. Reddy's Laboratories Limited has received five separate orders from the Joint Commissioner of Central Tax, Visakhapatnam, pertaining to tax demands, interest, and penalties for the financial years 2018-19 to 2022-23. The orders, dated December 31, 2025, and received on the same date, allege that the company availed excess input tax credit under the APGST Act 2017. The total penalty amounts levied are ₹1,89,30,110 for FY 2018-19, ₹80,41,186 for FY 2019-20, ₹3,52,95,063 for FY 2020-21, ₹1,45,04,023 for FY 2021-22, and ₹70,86,675 for FY 2022-23. The aggregate penalty amounts to approximately ₹8.4 crore. Dr. Reddy's Laboratories stated that based on their evaluation, there is no material impact on the company's financials, operations, or other activities. The company is evaluating the possibility of filing a necessary appeal with the appellate authority.

Limitations of AI summaries

AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.

Platforms like Prysm provide stock-level and portfolio-level analysis.

Why is Dr. Reddy's Laboratories Limited in the news today?

Dr. Reddy's Laboratories Limited (DRREDDY) is in the news due to the company has received tax demand and penalty orders, which could be seen as negative. however, the company has stated that there is no material impact on its financials and is considering an appeal, thus maintaining a neutral stance.

Other Regulatory FilingsLitigation UpdatesTaxation
Dr. Reddy's Laboratories LimitedDRREDDYhttps://prysm.fi/v2/analyze/DRREDDY

AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Dr. Reddy's Receives GST Demand Orders Totaling ₹8.4 Cr with Penalty

January 1, 2026, 10:29 AM

AI Sentiment Analysis

Top Queries to Ask About Dr. Reddy's Laboratories Limited

More Details on This News

Dr. Reddy's Laboratories Limited has received five separate orders from the Joint Commissioner of Central Tax, Visakhapatnam, pertaining to tax demands, interest, and penalties for the financial years 2018-19 to 2022-23. The orders, dated December 31, 2025, and received on the same date, allege that the company availed excess input tax credit under the APGST Act 2017.

The total penalty amounts levied are ₹1,89,30,110 for FY 2018-19, ₹80,41,186 for FY 2019-20, ₹3,52,95,063 for FY 2020-21, ₹1,45,04,023 for FY 2021-22, and ₹70,86,675 for FY 2022-23. The aggregate penalty amounts to approximately ₹8.4 crore.

Dr. Reddy's Laboratories stated that based on their evaluation, there is no material impact on the company's financials, operations, or other activities. The company is evaluating the possibility of filing a necessary appeal with the appellate authority.

See What Deep Dive Gives You — in Seconds

“what happens when you click Deep Dive “

Instant AI Summary - “Get clean, noise-free earnings breakdowns.”

PDF Insights - “Download detailed, AI-generated reports.”

Metrics Explained -“Key ratios & trends explained in simple language.”

Want to know if this news pushes your stock up or down?

Just tap

deep dive

More News on Dr. Reddy's Laboratories Limited

Discover more trending news on Prysm

View All